Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP
- PMID: 8129737
- PMCID: PMC1137988
- DOI: 10.1042/bj2980099
Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP
Abstract
We have investigated the effect of extracellular ATP on tumour-cell proliferation and GSH levels in Ehrlich-ascites-tumour-bearing mice. After daily administration of exogenous ATP (1 mmol/kg) during 7 days, we found a 56% inhibition of tumour growth, precisely when controls show the highest rates of cell proliferation and the highest levels of GSH. This effect is accompanied by a decrease in GSH content in the tumour, but not in normal tissues. The decrease in GSH concentration within the cancer cells is associated with a decrease in gamma-glutamylcysteine synthetase activity and in protein synthesis. Growth inhibition is mediated by generation of extracellular adenosine, which subsequently increases intracellular levels of ATP and decreases intracellular levels of UTP in the cancer cells. Our results suggest that inhibition of tumour growth by ATP is due to an adenosine-dependent pyrimidine starvation effect.
Similar articles
-
Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo.Biochem J. 1997 Jul 1;325 ( Pt 1)(Pt 1):183-9. doi: 10.1042/bj3250183. Biochem J. 1997. PMID: 9224645 Free PMC article.
-
Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.Biochem J. 1993 Jun 1;292 ( Pt 2)(Pt 2):477-83. doi: 10.1042/bj2920477. Biochem J. 1993. PMID: 8503882 Free PMC article.
-
Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays.Nat Med. 1995 Jan;1(1):84-8. doi: 10.1038/nm0195-84. Nat Med. 1995. PMID: 7584960
-
Regulation of tumour cell sensitivity to TNF-induced oxidative stress and cytotoxicity: role of glutathione.Biofactors. 1998;8(1-2):23-6. doi: 10.1002/biof.5520080105. Biofactors. 1998. PMID: 9699004 Review.
-
Mechanisms of adenosine-induced cytotoxicity and their clinical and physiological implications.Biofactors. 2006;27(1-4):213-30. doi: 10.1002/biof.5520270119. Biofactors. 2006. PMID: 17012777 Review.
Cited by
-
ATP promotes extracellular matrix biosynthesis of intervertebral disc cells.Cell Tissue Res. 2015 Feb;359(2):635-642. doi: 10.1007/s00441-014-2042-2. Epub 2014 Nov 19. Cell Tissue Res. 2015. PMID: 25407524 Free PMC article.
-
Adenosine triphosphate: established and potential clinical applications.Drugs. 1999 Aug;58(2):211-32. doi: 10.2165/00003495-199958020-00002. Drugs. 1999. PMID: 10473017 Review.
-
Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer.Invest New Drugs. 1998;16(1):81-5. doi: 10.1023/a:1006018610986. Invest New Drugs. 1998. PMID: 9740548 Clinical Trial.
-
Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo.Biochem J. 1997 Jul 1;325 ( Pt 1)(Pt 1):183-9. doi: 10.1042/bj3250183. Biochem J. 1997. PMID: 9224645 Free PMC article.
-
Purinergic signalling and cancer.Purinergic Signal. 2013 Dec;9(4):491-540. doi: 10.1007/s11302-013-9372-5. Purinergic Signal. 2013. PMID: 23797685 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources